Literature DB >> 25135638

Irreversible heavy chain transfer to chondroitin.

Mark E Lauer1, Vincent C Hascall2, Dixy E Green3, Paul L DeAngelis3, Anthony Calabro2.   

Abstract

We have recently demonstrated that the transfer of heavy chains (HCs) from inter-α-inhibitor, via the enzyme TSG-6 (tumor necrosis factor-stimulated gene 6), to hyaluronan (HA) oligosaccharides is an irreversible event in which subsequent swapping of HCs between HA molecules does not occur. We now describe our results of HC transfer experiments to chondroitin sulfate A, chemically desulfated chondroitin, chemoenzymatically synthesized chondroitin, unsulfated heparosan, heparan sulfate, and alginate. Of these potential HC acceptors, only chemically desulfated chondroitin and chemoenzymatically synthesized chondroitin were HC acceptors. The kinetics of HC transfer to chondroitin was similar to HA. At earlier time points, HCs were more widely distributed among the different sizes of chondroitin chains. As time progressed, the HCs migrated to lower molecular weight chains of chondroitin. Our interpretation is that TSG-6 swaps the HCs from the larger, reversible sites on chondroitin chains, which function as HC acceptors, onto smaller chondroitin chains, which function as irreversible HC acceptors. HCs transferred to smaller chondroitin chains were unable to be swapped off the smaller chondroitin chains and transferred to HA. HCs transferred to high molecular weight HA were unable to be swapped onto chondroitin. We also present data that although chondroitin was a HC acceptor, HA was the preferred acceptor when chondroitin and HA were in the same reaction mixture.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Chondroitin; Chondroitin Sulfate; Glycosaminoglycan; Heparan Sulfate; Hyaluronan

Mesh:

Substances:

Year:  2014        PMID: 25135638      PMCID: PMC4200270          DOI: 10.1074/jbc.M114.600809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion.

Authors:  Laura Scarchilli; Antonella Camaioni; Barbara Bottazzi; Veronica Negri; Andrea Doni; Livija Deban; Antonio Bastone; Giovanni Salvatori; Alberto Mantovani; Gregorio Siracusa; Antonietta Salustri
Journal:  J Biol Chem       Date:  2007-08-02       Impact factor: 5.157

2.  Tumour necrosis factor alpha-stimulated gene-6 inhibits osteoblastic differentiation of human mesenchymal stem cells induced by osteogenic differentiation medium and BMP-2.

Authors:  So Tsukahara; Ryuji Ikeda; Shin Goto; Kenichi Yoshida; Rie Mitsumori; Yoshiko Sakamoto; Atsushi Tajima; Toru Yokoyama; Satoshi Toh; Ken-ichi Furukawa; Ituro Inoue
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

3.  Coding sequence, exon-intron structure and chromosomal localization of murine TNF-stimulated gene 6 that is specifically expressed by expanding cumulus cell-oocyte complexes.

Authors:  C Fülöp; R V Kamath; Y Li; J M Otto; A Salustri; B R Olsen; T T Glant; V C Hascall
Journal:  Gene       Date:  1997-11-20       Impact factor: 3.688

4.  Acceptor specificity of the Pasteurella hyaluronan and chondroitin synthases and production of chimeric glycosaminoglycans.

Authors:  Breca S Tracy; Fikri Y Avci; Robert J Linhardt; Paul L DeAngelis
Journal:  J Biol Chem       Date:  2006-11-10       Impact factor: 5.157

5.  Specificity of the tumor necrosis factor-induced protein 6-mediated heavy chain transfer from inter-alpha-trypsin inhibitor to hyaluronan: implications for the assembly of the cumulus extracellular matrix.

Authors:  Durba Mukhopadhyay; Akira Asari; Marilyn S Rugg; Anthony J Day; Csaba Fülöp
Journal:  J Biol Chem       Date:  2004-01-05       Impact factor: 5.157

6.  Chemoenzymatic synthesis with distinct Pasteurella heparosan synthases: monodisperse polymers and unnatural structures.

Authors:  Alison E Sismey-Ragatz; Dixy E Green; Nigel J Otto; Martin Rejzek; Robert A Field; Paul L DeAngelis
Journal:  J Biol Chem       Date:  2007-07-11       Impact factor: 5.157

7.  TSG-6: a TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis.

Authors:  H G Wisniewski; R Maier; M Lotz; S Lee; L Klampfer; T H Lee; J Vilcek
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

8.  Synchronized chemoenzymatic synthesis of monodisperse hyaluronan polymers.

Authors:  Wei Jing; Paul L DeAngelis
Journal:  J Biol Chem       Date:  2004-08-05       Impact factor: 5.157

9.  Characterization of complexes formed between TSG-6 and inter-alpha-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.

Authors:  Marilyn S Rugg; Antony C Willis; Durba Mukhopadhyay; Vincent C Hascall; Erik Fries; Csaba Fülöp; Caroline M Milner; Anthony J Day
Journal:  J Biol Chem       Date:  2005-04-19       Impact factor: 5.157

10.  A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44.

Authors:  T H Lee; H G Wisniewski; J Vilcek
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  2 in total

1.  Metal Ion-dependent Heavy Chain Transfer Activity of TSG-6 Mediates Assembly of the Cumulus-Oocyte Matrix.

Authors:  David C Briggs; Holly L Birchenough; Tariq Ali; Marilyn S Rugg; Jon P Waltho; Elena Ievoli; Thomas A Jowitt; Jan J Enghild; Ralf P Richter; Antonietta Salustri; Caroline M Milner; Anthony J Day
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

2.  Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Is Constitutively Expressed in Adult Central Nervous System (CNS) and Associated with Astrocyte-mediated Glial Scar Formation following Spinal Cord Injury.

Authors:  Vivien J Coulson-Thomas; Mark E Lauer; Sara Soleman; Chao Zhao; Vincent C Hascall; Anthony J Day; James W Fawcett
Journal:  J Biol Chem       Date:  2016-07-19       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.